Fig. 4From: Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancerAssociation between positive microtubule-associated protein Tau (MAPT) staining and 10q23 (PTEN), 5q21 (CHD1), 6q15 (MAP3K7), 3p13 (FOXP1) deletions in (a) all cancers, (b) the TMPRSS2:ERG negative and (c) the TMPRSS2:ERG positive subsetBack to article page